“These are the president’s policies, and for JD Vance to question them like that is ridiculous. He is the commander in chief, ...
Revita is currently being studied under an open Investigational Device Exemption (IDE) in the U.S. and holds FDA Breakthrough Device designation for weight maintenance in patients discontinuing GLP-1 ...